uniQure N.V — Balance Sheet (NASDAQ:QURE) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 340.39 M809.18 M704.96 M831.69 M556.54 M Total liabilities 96.49 M213.4 M228.96 M624.02 M563.29 M Total equity 243.91 M595.78 M476.01 M207.67 M6.75 M Total liabilities & shareholders' equities 340.39 M809.18 M704.96 M831.69 M556.54 M Total debt ————— Net debt —————

uniQure N.V

uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.

뉴스

uniQure: Shares Tumble On Fresh FDA Controversy - What Investors Should Know (NASDAQ:QURE)

유니큐어, AMT-130 규제 경로 주목 속 실적 발표 예정

uniQure earnings in focus as AMT-130 regulatory path looms

유니큐어 주식, FDA 관계자 발언 후 스티펠 논평

Stifel comments on uniQure shares after FDA commissioner remarks

Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug

Applied Materials, Broadcom among market cap stock movers on Thursday

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Beats Revenue Estimates

유니큐어, FDA 언급에 급락…유전자 치료제 임상 관련

UniQure stock tumbles on FDA comments about gene therapy trial

uniQure, Wolfe Research에서 ’Peerperform’ 등급으로 시작

uniQure stock initiated at Peerperform by Wolfe Research